PB 47 of 2013
National Health (Pharmaceutical Benefits – Therapeutic Groups) Amendment Determination 2013 (No. 3)
National Health Act 1953
I, ADRIANA PLATONA, Assistant Secretary, Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health, make this determination under subsection 84AG(1) of the National Health Act 1953.
Dated         26  July 2013
 
 
 
 
 
 
 
 
 
 
 
ADRIANA PLATONA
 
Assistant Secretary
Pharmaceutical Evaluation Branch
Pharmaceutical Benefits Division
Department of Health and Ageing
 
1              Name of Determination
       (1)     This Determination is the National Health (Pharmaceutical Benefits – Therapeutic Groups) Amendment Determination 2013 (No. 3).
       (2)     This Determination may also be cited as PB 47 of 2013.
2              Commencement
                This Determination commences on 1 August 2013.
 
 
3              Amendments to PB 1 of 2010
Schedule 1 amends the National Health (Pharmaceutical Benefits – Therapeutic Groups) Determination 2010 (PB 1 of 2010).
 
 
Schedule 1             Amendments
 
[1]      Section 4 Definitions
    omit:
ACE inhibitor group means the Angiotensin converting enzyme inhibitor group.
 
[2]      Omit entry for Schedule 1, Part 1